Investing Profile

Laia Crespo

InvestorVC
Head of Investments at Sanofi Ventures
Photo of Laia Crespo, Investor at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$5.0M - $10.0M
$7.5M
10
CompanyStageDateRound SizeTotal Raised
Splice Bio
Series BJun 2025$140M
$190M
Co-investors: Joël Jean-Mairet (Ysios Capital), Carole Nuechterlein (Roche Venture Fund), Beat Steffen (Novartis Venture Fund), Daniela Begolo (EQT Life Sciences), Sylvain Sachot (Asabys Partners)
Eligo Bioscience
Series BDec 2023$30M
$30M
QurAlis
Series BMar 2023$88M
$140M
Co-investors: Amy Schulman (Polaris Partners), Stephen Thompson (Brandon Capital Partners), Jeffrey Moore (MP Healthcare Venture Management), Johannes Fruehauf (Mission BioCapital), Roel Bulthuis (INKEF Capital)
OMass Therapeutics
Series BApr 2022$95M
$95M
Co-investors: Diana Bernstein (Northpond Ventures)
Lava Therapeutics
Series CSep 2020$83M
$100M
Co-investors: Guido Magni (Versant Ventures), Nanna Luneborg (Forbion), Joël Jean-Mairet (Ysios Capital)
Inbiomotion
Series BMar 2016$2M
Series AJun 2012$2M
$4M
Co-investors: Jose Mesa (Alta Life Sciences), Joël Jean-Mairet (Ysios Capital)
Minoryx Therapeutics
Series AOct 2015$22M
$81M
Co-investors: Pablo Cironi (Caixa Capital), Carlos Esteban (Faber), Thierry Laugel (Kurma Partners), Monique Schiersing (Roche Venture Fund)
AM Pharma
Series ESep 2014$16M
Series DSep 2011$40M
$210M
Co-investors: Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion)